Biological Process
| angiogenesis | | ISO | RGD:1617631 | 1624291 | MGI:MGI:1331270|PMID:9990854 | RGD | MGI:MGI:1331270 PMID:9990854 |
| axon guidance | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2149059|PMID:11532925 | RGD | MGI:MGI:2149059 PMID:11532925 |
| axon guidance | | ISO | RGD:1617631 | 1624291 | MGI:MGI:84499|PMID:8947026 | RGD | MGI:MGI:84499 PMID:8947026 |
| axon guidance | | ISO | RGD:1617631 | 1624291 | MGI:MGI:1859095|PMID:10839360 | RGD | MGI:MGI:1859095 PMID:10839360 |
| axonal fasciculation | | ISO | RGD:1617631 | 1624291 | MGI:MGI:84499|PMID:8947026 | RGD | MGI:MGI:84499 PMID:8947026 |
| biological_process | | ND | | 1598407 | 4/2007: no relevant rat data | RGD | |
| camera-type eye morphogenesis | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2149765 | RGD | MGI:MGI:2675767 PMID:12971893 |
| camera-type eye morphogenesis | | IEA | Ensembl:ENSMUSP00000101471 | 1600115 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| cell morphogenesis | | ISO | RGD:1617631 | 1624291 | MGI:MGI:107708 | RGD | MGI:MGI:3766849 PMID:17686994 |
| central nervous system projection neuron axonogenesis | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2675767|PMID:12971893 | RGD | MGI:MGI:2675767 PMID:12971893 |
| central nervous system projection neuron axonogenesis | | IEA | Ensembl:ENSMUSP00000101471 | 1600115 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| commissural neuron axon guidance | | ISO | RGD:1617631 | 1624291 | MGI:MGI:81675|PMID:8689685 | RGD | MGI:MGI:81675 PMID:8689685 |
| corpus callosum development | | ISO | RGD:1617631 | 1624291 | MGI:MGI:84499|PMID:8947026 | RGD | MGI:MGI:84499 PMID:8947026 |
| dendritic spine development | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2683349|PMID:14691139 | RGD | MGI:MGI:2683349 PMID:14691139 |
| dendritic spine morphogenesis | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2683349|PMID:14691139 | RGD | MGI:MGI:2683349 PMID:14691139 |
| ephrin receptor signaling pathway | | ISO | RGD:1617631 | 1624291 | MGI:MGI:3766849|PMID:17686994 | RGD | MGI:MGI:3766849 PMID:17686994 |
| ephrin receptor signaling pathway | | ISO | RGD:1617631 | 1624291 | MGI:MGI:4881358|PMID:21029865 | RGD | MGI:MGI:4881358 PMID:21029865 |
| inner ear morphogenesis | | ISO | RGD:1617631 | 1624291 | MGI:MGI:1859095|PMID:10839360 | RGD | MGI:MGI:1859095 PMID:10839360 |
| learning | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2149765 | RGD | MGI:MGI:2155580 PMID:11754835 |
| learning | | IEA | Ensembl:ENSMUSP00000101471 | 1600115 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| negative regulation of axonogenesis | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2675767|PMID:12971893 | RGD | MGI:MGI:2675767 PMID:12971893 |
| negative regulation of axonogenesis | | IEA | Ensembl:ENSMUSP00000101471 | 1600115 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| optic nerve morphogenesis | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2149765 | RGD | MGI:MGI:2675767 PMID:12971893 |
| optic nerve morphogenesis | | IEA | Ensembl:ENSMUSP00000101471 | 1600115 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| organ morphogenesis | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2149670 | RGD | MGI:MGI:3047196 PMID:15223334 |
| palate development | | ISO | RGD:1617631 | 1624291 | MGI:MGI:84499|PMID:8947026 | RGD | MGI:MGI:84499 PMID:8947026 |
| peptidyl-tyrosine phosphorylation | | ISO | RGD:1617631 | 1624291 | MGI:MGI:3766849|PMID:17686994 | RGD | MGI:MGI:3766849 PMID:17686994 |
| peptidyl-tyrosine phosphorylation | | ISO | RGD:1617631 | 1624291 | MGI:MGI:4881358|PMID:21029865 | RGD | MGI:MGI:4881358 PMID:21029865 |
| peptidyl-tyrosine phosphorylation | | IEA | Ensembl:ENSMUSP00000101471 | 1600115 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| phosphorylation | | ISO | RGD:1617631 | 1624291 | MGI:MGI:1327089|PMID:9883737 | RGD | MGI:MGI:1327089 PMID:9883737 |
| positive regulation of long-term neuronal synaptic plasticity | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2149765 | RGD | MGI:MGI:2155573 PMID:11754836 |
| positive regulation of long-term neuronal synaptic plasticity | | IEA | Ensembl:ENSMUSP00000101471 | 1600115 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| positive regulation of synapse assembly | | ISO | RGD:1617631 | 1624291 | MGI:MGI:4881358|PMID:21029865 | RGD | MGI:MGI:4881358 PMID:21029865 |
| positive regulation of synapse assembly | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2683349|PMID:14691139 | RGD | MGI:MGI:2683349 PMID:14691139 |
| protein phosphorylation | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2675767|PMID:12971893 | RGD | MGI:MGI:2675767 PMID:12971893 |
| regulation of axonogenesis | | ISO | RGD:1617631 | 1624291 | MGI:MGI:3037383|PMID:14988728 | RGD | MGI:MGI:3037383 PMID:14988728 |
| regulation of body fluid levels | | ISO | RGD:1617631 | 1624291 | MGI:MGI:1859095|PMID:10839360 | RGD | MGI:MGI:1859095 PMID:10839360 |
| regulation of neuronal synaptic plasticity | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2149765 | RGD | MGI:MGI:2155580 PMID:11754835 |
| retinal ganglion cell axon guidance | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2675767|PMID:12971893 | RGD | MGI:MGI:2675767 PMID:12971893 |
| retinal ganglion cell axon guidance | | IEA | Ensembl:ENSMUSP00000101471 | 1600115 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| transmembrane receptor protein tyrosine kinase signaling pathway | | ISO | RGD:1617631 | 1624291 | MGI:MGI:3037383|PMID:14988728 | RGD | MGI:MGI:3037383 PMID:14988728 |
| urogenital system development | | ISO | RGD:1617631 | 1624291 | MGI:MGI:3047196|PMID:15223334 | RGD | MGI:MGI:3047196 PMID:15223334 |
Cellular Component
| axon | | ISO | RGD:1617631 | 1624291 | MGI:MGI:81675|PMID:8689685 | RGD | MGI:MGI:81675 PMID:8689685 |
| cellular_component | | ND | | 1598407 | 4/2007: no relevant rat data | RGD | |
| dendrite | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2683349|PMID:14691139 | RGD | MGI:MGI:2683349 PMID:14691139 |
| integral to plasma membrane | | IEA | InterPro:IPR016257 | 1600115 | GO_REF:0000002 | InterPro | GO_REF:0000002 |
| integral to plasma membrane | | ISO | RGD:1617631 | 1624291 | MGI:MGI:81675|PMID:8689685 | RGD | MGI:MGI:81675 PMID:8689685 |
| neuronal cell body | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2675767|PMID:12971893 | RGD | MGI:MGI:2675767 PMID:12971893 |
| neuronal cell body | | IEA | Ensembl:ENSMUSP00000101471 | 1600115 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
Molecular Function
| ATP binding | | IEA | UniProtKB-KW:KW-0067 | 1600115 | GO_REF:0000038 | UniProtKB | GO_REF:0000038 |
| axon guidance receptor activity | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2149059|PMID:11532925 | RGD | MGI:MGI:2149059 PMID:11532925 |
| axon guidance receptor activity | | IEA | Ensembl:ENSMUSP00000101471 | 1600115 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| ephrin receptor activity | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2155002|PMID:11780069 | RGD | MGI:MGI:2155002 PMID:11780069 |
| ephrin receptor activity | | IEA | Ensembl:ENSMUSP00000101471 | 1600115 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| molecular_function | | ND | | 1598407 | 4/2007: no relevant rat data | RGD | |
| protein binding | | ISO | RGD:1617631 | 1624291 | UniProtKB:P52800 | RGD | MGI:MGI:2155002 PMID:11780069 |
| protein binding | | ISO | RGD:1617631 | 1624291 | UniProtKB:Q02013 | RGD | MGI:MGI:1859095 PMID:10839360 |
| protein binding | | ISO | RGD:1617631 | 1624291 | UniProtKB:Q5FWH6-2 | RGD | MGI:MGI:4881358 PMID:21029865 |
| protein binding | | ISO | RGD:1617631 | 1624291 | UniProtKB:P05480|UniProtKB:P34152 | RGD | MGI:MGI:3694172 PMID:16298995 |
| protein binding | | ISO | RGD:1617631 | 1624291 | UniProtKB:Q925T6 | RGD | MGI:MGI:1327089 PMID:9883737 |
| protein binding | | ISO | RGD:1617631 | 1624291 | MGI:MGI:104757 | RGD | MGI:MGI:2675767 PMID:12971893 |
| protein binding | | ISO | RGD:1617631 | 1624291 | UniProtKB:P35438 | RGD | MGI:MGI:2155580 PMID:11754835 |
| protein tyrosine kinase activity | | ISO | RGD:1617631 | 1624291 | MGI:MGI:1327089|PMID:9883737 | RGD | MGI:MGI:1327089 PMID:9883737 |
| receptor activity | | ISO | RGD:1617631 | 1624291 | MGI:MGI:2155002|PMID:11780069 | RGD | MGI:MGI:2155002 PMID:11780069 |
| receptor binding | | ISO | RGD:1617631 | 1624291 | UniProtKB:P35438 | RGD | MGI:MGI:2155580 PMID:11754835 |
| receptor binding | | IEA | Ensembl:ENSMUSP00000101471 | 1600115 | GO_REF:0000019 | ENSEMBL | GO_REF:0000019 |
| transmembrane-ephrin receptor activity | | ISO | RGD:1617631 | 1624291 | MGI:MGI:4881358|PMID:21029865 | RGD | MGI:MGI:4881358 PMID:21029865 |
| 1578766 | Tcas11 | Tongue tumor susceptibility QTL 11 | 4.12 | | Tongue tumor susceptibility | tongue tumor number | 5 | 17517235 | 168005953 | Rat |
| 61393 | Bp7 | Blood pressure QTL 7 | 4.5 | .0001 | Blood pressure | salt-loaded systolic | 5 | 62555131 | 168174140 | Rat |
| 1354598 | Srn6 | Serum renin concentration QTL 6 | 3.8 | | Renin concentration | serum | 5 | 71971592 | 157597184 | Rat |
| 1302790 | Scl20 | Serum cholesterol QTL 20 | 6.4 | .0001 | Lipid level | cholesterol level | 5 | 86116638 | 172913795 | Rat |
| 2317056 | Wbc3 | White blood cell count QTL 3 | 2.51 | .01 | White blood cell count | | 5 | 112840801 | 157840801 | Rat |
| 1549838 | Bss4 | Bone structure and strength QTL 4 | 9.2 | | Bone structure and strength | Femoral midshaft moment of inertia | 5 | 113689301 | 158689301 | Rat |
| 7207481 | Bss106 | Bone structure and strength QTL 106 | 7.9 | | Bone strength | Femoral ultimate force | 5 | 113689301 | 158689301 | Rat |
| 7207486 | Bss109 | Bone structure and strength QTL 109 | | | Bone strength | Femoral energy to break | 5 | 113689301 | 158689301 | Rat |
| 7207488 | Bss110 | Bone structure and strength QTL 1 | 8.4 | | Bone strength | Femoral stiffness | 5 | 113689301 | 158689301 | Rat |
| 7207491 | Bss112 | Bone structure and strength QTL 112 | 7 | | Bone structure | Femoral midshaft cortical area | 5 | 113689301 | 158689301 | Rat |
| 1298089 | Scl14 | Serum cholesterol level QTL 14 | 5.8 | .0004 | Lipid level | cholesterol | 5 | 115772027 | 160772027 | Rat |
| 1598847 | Cm62 | Cardiac mass QTL 62 | 3.4 | | Cardiac mass | | 5 | 115772027 | 160772027 | Rat |
| 2293642 | Bss37 | Bone structure and strength QTL 37 | 4.64 | .0001 | Bone strength | | 5 | 126963761 | 157597184 | Rat |
| 724525 | Bp147 | Blood pressure QTL 147 | 4.3 | .0001 | Blood pressure | systolic | 5 | 132950669 | 173096209 | Rat |
| 1598819 | Bp292 | Blood pressure QTL 292 | 4.3 | | Blood pressure | systolic | 5 | 134356746 | 173096209 | Rat |
| 1598861 | Cm64 | Cardiac mass QTL 64 | 2.9 | | Cardiac mass | | 5 | 134356746 | 173096209 | Rat |
| 634349 | Bp139 | Blood pressure QTL 139 | | .001 | Blood pressure | systolic | 5 | 135877124 | 173096209 | Rat |
| 70156 | Niddm30 | Non-insulin dependent diabetes mellitus QTL 30 | 3.98 | | Glucose level | postprandial | 5 | 135910738 | 157584492 | Rat |
| 738018 | Anxrr4 | Anxiety related response QTL 4 | 5.1 | | Anxiety response | open field inner locomotion | 5 | 136765530 | 173096209 | Rat |
| 631505 | Bp103 | Blood pressure QTL 103 | 3.2 | | Blood pressure | systolic | 5 | 139690801 | 171801867 | Rat |
| 631562 | Apr2 | Acute phase response QTL 2 | 3.7 | | Alpha1 acid glycoprotein level | pristane induced | 5 | 142573432 | 173096209 | Rat |
| 61444 | Strs2 | Sensitivity to stroke QTL 2 | 4.7 | | Stroke susceptibility | latency until stroke | 5 | 142575172 | 173096209 | Rat |
| 1331721 | Bp210 | Blood pressure QTL 210 | 3.413 | | Blood pressure | time series calculation | 5 | 149757277 | 173096209 | Rat |
| 2302369 | Scl60 | Serum cholesterol level QTL 60 | 3.13 | | Lipid level | serum total cholesterol | 5 | 150236110 | 167844737 | Rat |
| 631263 | Cm24 | Cardiac mass QTL 24 | 3.5 | | Cardiac mass | left ventricle | 5 | 150310201 | 165073513 | Rat |
| 1300119 | Bp180 | Blood pressure QTL 180 | 3.82 | | Blood pressure | salt-loaded time series calculation | 5 | 151039725 | 164343989 | Rat |
| 2313096 | Bmd78 | Bone mineral density QTL 78 | 3.1 | .0001 | Bone mineral density | | 5 | 151060403 | 168006088 | Rat |